However, we and others have observed that anti-tumor T cells in DC-vaccinated human and mouse glioma hosts predominantly recognize Trp-2, or dopachrome tautamerase (DCT; [44], [27]), which has been shown to enhancee stem-like properties in neural progenitors [45]. This evidence concerns the gene DCT and central nervous system cancer.